{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:26:28Z","timestamp":1778797588303,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.orcp.2011.03.011","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T01:41:02Z","timestamp":1304214062000},"page":"e327-e334","source":"Crossref","is-referenced-by-count":5,"title":["Telmisartan effectively improves insulin sensitivity in hypertensive patients with insulin resistance"],"prefix":"10.1016","volume":"5","author":[{"given":"Tetsuji","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichitaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Wakisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yufu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunori","family":"Saikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2011.03.011_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1301\/nr.2004.jul.S120-S126","article-title":"The epidemiology of central fat distribution in relation to disease","volume":"62","author":"Pi-Sunyer","year":"2004","journal-title":"Nutr Rev"},{"key":"10.1016\/j.orcp.2011.03.011_bib0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension","volume":"286","author":"Sowers","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0015","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.orcp.2011.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.orcp.2011.03.011_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumada","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2004.09.037","article-title":"Biological control through regulated transcriptional coactivators","volume":"119","author":"Spiegelman","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.orcp.2011.03.011_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR(gamma) and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.orcp.2011.03.011_bib0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.orcp.2011.03.011_bib0050","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0055","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.2337\/diabetes.54.12.3442","article-title":"Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity","volume":"54","author":"Schupp","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2011.03.011_bib0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2011.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0075","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.orcp.2011.03.011_bib0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.orcp.2011.03.011_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.orcp.2011.03.011_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep.20282","article-title":"Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice","volume":"40","author":"Masaki","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.orcp.2011.03.011_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1463-1326.2007.00755.x","article-title":"The effect of thiazolidinediones on adiponectin serum level: a meta-analysis","volume":"10","author":"Riera-Guardia","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2011.03.011_bib0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.orcp.2011.03.011_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1291\/hypres.30.49","article-title":"Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome","volume":"30","author":"Bahadir","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.orcp.2011.03.011_bib0110","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2169\/internalmedicine.49.3189","article-title":"Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients","volume":"49","author":"Watanabe","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.orcp.2011.03.011_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5551\/jat.E588","article-title":"Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (hmw)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity","volume":"16","author":"Komiya","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.orcp.2011.03.011_bib0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1291\/hypres.26.669","article-title":"Role of insulin resistance in nondipper essential hypertensive patients","volume":"26","author":"Anan","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.orcp.2011.03.011_bib0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1067\/mlc.2000.105617","article-title":"Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats","volume":"135","author":"Ikeda","year":"2000","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.orcp.2011.03.011_bib0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1024109007392","article-title":"Effect of an ACE inhibitor and an AT1 receptor antagonist on cardiac hypertrophy","volume":"248","author":"Shikata","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.orcp.2011.03.011_bib0135","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0735-1097(02)02860-7","article-title":"Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II","volume":"41","author":"Seccia","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0140","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0145","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0735-1097(02)02953-4","article-title":"C-reactive protein and other inflammatory risk markers in acute coronary syndromes","volume":"41","author":"Blake","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0155","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/01.CIR.0000015126.83143.B4","article-title":"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","article-title":"A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis","volume":"106","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0165","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.0000061916.95736.E5","article-title":"C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2011.03.011_bib0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mhj.2001.116699","article-title":"Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis","volume":"142","author":"Prasad","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.orcp.2011.03.011_bib0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","article-title":"Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients","volume":"42","author":"Koh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.orcp.2011.03.011_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2011.03.011_bib0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2011.03.011_bib0190","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.orcp.2011.03.011_bib0195","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diabetes.52.4.942","article-title":"Association between adiponectin and mediators of inflammation in obese women","volume":"52","author":"Engeli","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2011.03.011_bib0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diabres.2010.09.011","article-title":"The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis","volume":"90","author":"Zhao","year":"2010","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X11000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X11000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T03:55:31Z","timestamp":1543809331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X11000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1871403X11000184"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2011.03.011","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}